COVID-19 diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Sabawoon Mirwais (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, exportpages, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
4,937 edits
No edit summary
Sabawoon Mirwais (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, exportpages, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
4,937 edits
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{COVID-19}}
{{COVID-19}}
{{CMG}}{{cv}}{{AE}}{{sab}}
{{CMG}}{{AE}}{{sab}}


==Overview==
==Overview==

Revision as of 15:23, 13 April 2020

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 diagnostic study of choice

CDC on COVID-19 diagnostic study of choice

COVID-19 diagnostic study of choice in the news

Blogs on COVID-19 diagnostic study of choice

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

The diagnostic criteria for suspected and confirmed cases of Coronavirus disease 2019 (COVID-19) is tabulated in the section below.

Diagnostic Study of Choice

Diagnostic Criteria

The diagnostic criteria for suspected and confirmed cases of Coronavirus disease 2019 (COVID-19) is tabulated below:[1][2][3][4][5][6]

Case Diagnostic Criteria
Suspected Case Anyone with a history of epidemiology and any two of the clinical manifestations or anyone without epidemiological history and three of the clinical manifestations is considered to be a suspected case:

1) Epidemiological history:

  • Within 14 days before the disease onset, there is a travel history or living history in Wuhan or other areas with local cases
  • Within 14 days before the disease onset, there is contact with patients who had fever or respiratory symptoms from Wuhan or other areas with local cases
  • A clustering of patients or a contact with patients infected with the SARS-CoV-2


2) Clinical manifestations:

  • Fever and/or respiratory symptoms
  • With the above-mentioned imaging characteristics of pneumonia
  • The total number of leukocytes in the early stage of the disease is normal or decreased, or the lymphocyte count is decreased
Confirmed Case Any suspected case with one of the following pathogenic features is reclassified as a confirmed case:
  • Positive results of SARS-CoV-2 nucleic acids by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) of respiratory or blood specimens
  • DNA highly homologous to SARS-CoV-2 by genetic sequencing of viral genes in respiratory or blood specimens

References

  1. ↑ Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia'an; Yu, Ting; Zhang, Xinxin; Zhang, Li (2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". The Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. ISSN 0140-6736.
  2. ↑ "C.N.H. Commission Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection China National Health Commission, Beijing (2020) (in Chinese)". line feed character in |title= at position 18 (help)
  3. ↑ "Technology, M.e.g.o.T.h.a.t.T.M.C.o.H.U.o.S.a. A rapid guideline for the diagnosis and treatment of pneumonia with new coronavirus infection (Third edition)".
  4. ↑ "Union Hospital T.M.C., Huazhong University of Science and Technology., Wuhan union hospital manage the 2019 new coronavirus infection strategies and instructions (in Chinese)". line feed character in |title= at position 15 (help)
  5. ↑ "[Diagnosis and clinical management of 2019 novel coronavirus infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)]". Zhonghua Nei Ke Za Zhi (in Chinese). 59 (3): 186–188. February 2020. doi:10.3760/cma.j.issn.0578-1426.2020.03.003. PMID 32023681 Check |pmid= value (help).
  6. ↑ "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected".
Retrieved from "https://www.wikidoc.org/index.php?title=COVID-19_diagnostic_study_of_choice&oldid=1604409"